Image via Unsplash.
Hemorrhage is the leading preventable cause of death after trauma, accounting for roughly one-third of all trauma-related fatalities. It doesn’t matter if it’s a shrapnel wound on a battlefield, a jagged tear from a car accident, or a complication on a sterile operating table — when a major vessel is breached, immediate medical intervention is essential.
Now, researchers at the Korea Advanced Institute of Science and Technology (KAIST) have developed a sci-fi solution. They call it AGCL: a powder that transforms into a lifesaving instant hydrogel the millisecond it touches human blood.
The Alchemy of Blood
Our blood is a complex cocktail. Beyond the red and white cells, it is naturally rich in calcium ions — kept within a razor-thin physiological range to keep our hearts beating. The KAIST team decided to leverage this internal chemistry rather than just trying to plug the wound from the outside.
AGCL is a cocktail of four ingredients: alginate (derived from seaweed), gellan gum, chitosan (often sourced from shellfish), and a glutaraldehyde crosslinker. When this dry powder is poured into a bleeding wound, it reacts to the blood almost instantly, turning it into gel, solidifying into a physical barrier. In laboratory tests, AGCL transitioned from a loose powder to a solid, adhesive hydrogel in roughly one second.
Even if the wound is irregular, the powder can fill the space with ease. It’s kind of like pouring liquid concrete into a rough hole, only the concrete is biocompatible and the hole is a human wound.
The material’s blood uptake ratio is a staggering 725%, meaning it effectively mops up the blood while simultaneously sealing the breach.
A Biological Weld
The researchers put AGCL through a gauntlet of mechanical stress tests. It held fast even under mixed-mode loading, where it was pulled and twisted simultaneously. More importantly, it survived the bursting pressure test. To see if the powder would dislodge under high-pressure arterial bleeds, the team pushed it to the limit. AGCL held firm against pressures of 152.7 mmHg — comfortably above the standard human systolic pressure of 120 mmHg.
It is, for all intents and purposes, a biological weld. But it has another trick up its sleeve.
×
Thank you! One more thing…
Please check your inbox and confirm your subscription.
Other blood-stopping methods either have to be surgically removed or sit in the body as an inert lump. AGCL is regenerative. Because it mostly consists of sugars, the body recognizes it as a scaffolding rather than a foreign invader. The chitosan in the mix provides a built-in defense system, offering over 99% antibacterial efficacy. In a world where hospital-acquired infections and antibiotic-resistant superbugs are a constant threat, having a bandage that actively kills E. coli on contact is a massive advantage.
When tested on animal models, the researchers found that AGCL didn’t just sit on the wound; it invited the body to rebuild. In skin injury models, the AGCL-treated wounds closed significantly faster than the control groups. By day 12, the wounds were nearly fully re-epithelialized — meaning the new skin had grown back over the gap. Under the microscope, the team saw robust neovascularization (the growth of new blood vessels) and organized collagen deposition.
Is it Ready for the Hospital?
The material was tested on mice. But as with any new biomaterial, the path from mice to men is long. While the mammalian blood response is remarkably similar across species due to our shared calcium-sensing receptors, human clinical trials will be the ultimate test. There is also the question of cost, though the ingredients like alginate and chitosan are relatively cheap and abundant.
But the core achievement here is undeniable. Even if the final recipe needs a bit of tweaking, AGCL represents a shift towards material that doesn’t just plug bleeding but rather uses the blood’s properties to seal it off directly. It’s a much smarter solution.
The researchers tested the powder’s shelf life by leaving it in an open container, exposed to the humid, fluctuating air of a standard room for two full years, without sealing it. Even after all this time, the powder still worked perfectly. It still gelled in one second. It still absorbed 725% of its weight in blood.
This robust storage stability means AGCL could be carried in a soldier’s rucksack in the desert, kept in the glovebox of a rural ambulance, or stocked in remote clinics in developing nations where electricity for refrigeration is a luxury. It is a high-tech solution for a low-tech problem.
The study was published in Advanced Functional Materials.